Baltimore-With their excellent therapeutic profiles, the prostaglandin analogues and their related compounds have launched glaucoma treatment into an exciting new era, according to Eve J. Higginbotham, MD.

Related Content

November 22nd 2024

Avant Technologies and Ainnova Tech partner to advance retinal camera with AI-driven diagnostic platform

EnVision Summit 2025: Advancing Ophthalmology and Optometry Together

November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

November 22nd 2024

AlloVir and Kalaris Therapeutics announce all-stock merger to focus on retinal diseases

Robert Chang, MD, discusses the impact of large language models on glaucoma care and AI in ophthalmology

November 5th 2024

Innovation Series: Putting the buzz of large language models in ophthalmology into perspective with Robert T. Chang, MD

November 21st 2024

USC researchers receive $6 million CIRM grant to advance novel dry AMD therapy

November 21st 2024

Recent changes to cornea: Preferred Practice Patterns

Related Content

November 22nd 2024

Avant Technologies and Ainnova Tech partner to advance retinal camera with AI-driven diagnostic platform

November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

November 22nd 2024

AlloVir and Kalaris Therapeutics announce all-stock merger to focus on retinal diseases

November 5th 2024

Innovation Series: Putting the buzz of large language models in ophthalmology into perspective with Robert T. Chang, MD

November 21st 2024

USC researchers receive $6 million CIRM grant to advance novel dry AMD therapy

November 21st 2024

Recent changes to cornea: Preferred Practice Patterns

Do Not Sell My Personal Information

Job Board

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777